{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-162003","form_type":"8-K","ticker":"RARE","cik":"0001515673","company_name":"Ultragenyx Pharmaceutical Inc.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.773545+00:00","generated_at":"2026-06-01T04:05:39.589860+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ultragenyx raises ~$330.7M in public offering of common stock and pre-funded warrants","bullets":["Offering of 7,435,898 shares at $39/share plus pre-funded warrants for 1,538,501 shares at $38.999.","Net proceeds expected ~$330.7M after underwriting discounts and expenses.","Underwriters granted 30-day option to purchase up to 1,346,153 additional shares.","Closing expected June 17, 2024; use of proceeds for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-162003","json":"https://secwatch.observer/filing/0001193125-24-162003.json","markdown":"https://secwatch.observer/filing/0001193125-24-162003.md","text":"https://secwatch.observer/filing/0001193125-24-162003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1515673/000119312524162003/0001193125-24-162003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1515673/000119312524162003/d785247d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:05:39.589860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}